8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 1, 2006

CONMED CORPORATION

(Exact name of registrant as specified in its charter)

New York	0-16093	16-0977505
(State or other jurisdiction of	(Commission	(I.R.S. Employer
incorporation or organization)	File Number)	Identification No.)

525 French Road

Utica, New York 13502

(Address of principal executive offices, including zip code)

(315) 797-8375

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01 Entry into a Material Definitive Agreement; Item 5.02 Departure of Principal Officers; Election of Directors; Appointment of Principal Officers

On November 1, 2006, CONMED Corporation announced that its Board of Directors has elected Joseph J. Corasanti to be its next Chief Executive Officer, effective January 1, 2007. He currently serves as President and Chief Operating Officer. He will succeed Eugene R. Corasanti who will continue to serve as Chairman of the Board of Directors in the capacity of non-executive Chairman. Mr. Eugene Corasanti will relinquish his executive functions at the Company on December 31, 2006, remaining employed by the Company as Vice Chairman.

Mr. Eugene Corasanti is the founder of CONMED Corporation and has led its growth from a start-up in the 1970’s to its present position as a leader in the medical technology marketplace. Mr. Joseph Corasanti joined the Company in 1993 as General Counsel and Vice President of Legal Affairs. He was elected to the Board of Directors in 1994. In 1998 he assumed the role of Executive Vice-President and General Manager. In 1999 he was appointed to his present position of President and Chief Operating Officer. He will remain a Director of the Company.

Mr. Joseph Corasanti will add the title of Chief Executive Officer effective January 1, 2007, in addition to his present title as President. He is also a member of the Board of Directors of II-VI, Inc. (Nasdaq: IIVI), a manufacturer of optical and electro-optical components and devices for infrared, e-ray, gamma-ray, telecommunication and other applications, where he also serves as a member of the audit committee. He holds a B.A. degree in Political Science from Hobart College and a J.D degree from Whittier College School of Law. He is admitted to the state bar of both New York and California. Prior to joining CONMED Corporation, he worked as a trial attorney in the Los Angeles office of Morgan Wenzel and McNichols, a practice concentrating on business and civil litigation.

Section 9              Financial Statements and Exhibits

Item 9.01  Financial Statements and Exhibits.

(c) Exhibits

The following exhibits are included herewith:

Exhibit No.Description of Exhibit

10.1 Amendment No. 1 to November 12, 2004 Employment Agreement between the Company and Joseph J. Corasanti, dated October 31, 2006

10.2 Employment Agreement between the Company and Eugene R. Corasanti, dated October 31, 2006

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CONMED CORPORATION
(Registrant)
By:	Robert D. Shallish, Jr
	Vice President - Finance and
	Chief Financial Officer

Date: November 1, 2006

EX-10.1

Exhibit 10.1

Employment Agreement

October 31, 2006

Mr. Eugene R. Corasanti

525 French Road

Utica, New York 13502

Dear Mr. Corasanti:

In consideration of the mutual promises herein contained, CONMED Corporation, a New York corporation (hereinafter the “Company”), and you hereby agree that, commencing January 1, 2007 (the “Effective Date”), you will be employed by the Company on the following terms and conditions:

1.Employment.

The Company hereby agrees that you will be employed to serve as a Vice Chairman of the Company during the term of employment set forth in Section 2 of this Agreement. You hereby agree to serve in any such capacity during such term of employment. On the Effective Date, you will become the Non-Executive Chairman of the Board of Directors of the Company and the Company shall cause you to be nominated for election to the Board of Directors of the Company (and shall use its reasonable best efforts to cause you to remain the Non-Executive Chairman) during your term of employment under this Agreement. The Company will provide an office for you either in Utica, New York, or in Largo, Florida, or at such other location as may be mutually agreeable.

2.Term of Employment.

Subject to the provisions for termination pursuant to Section 5 of the Agreement, your term of employment under this Agreement shall commence on the Effective Date and continue until terminated by you or the Company.

3. Duties During Term of Employment.

During your term of employment under this Agreement, you shall devote such business time, attention and efforts to the affairs of the Company and its subsidiaries and affiliates as is reasonably required and shall perform such executive and administrative duties for the Company and subsidiaries and affiliates as you may reasonably be called upon to perform, from time to time, by the Board of Directors and/or Chief Executive Officer of the Company.

4. Compensation and Benefits.

(a) Base Annual Salary.

The Company shall pay to you during your term of employment under this Agreement a base annual salary at the rate of at least $104,000 per year, payable in equal weekly installments during each year of your term of employment. It is understood that the Board of Directors of the Company may in its discretion review from time to time your base annual salary and in its discretion may from time to time increase your base annual salary and/or grant bonuses if it determines that circumstances justify any such increase and/or bonuses.

(b) Deferred Compensation.

Commencing on the Effective Date, the deferred compensation arrangements established under Section 4(b) of your prior employment agreement with the Company, as amended, shall be paid out to you (or, in the event of your death, to your estate) over the 120 months following the Effective Date (with the last payment to be made in December of 2016) pursuant to the terms of Section 4(b) of your prior employment agreement (including, without limitations, the interest crediting mechanics). For the avoidance of doubt, payment under this Section 4(b) shall be made regardless of the time of your “retirement”.

(c) Benefit Plans.

You also shall be entitled to participate in all life and health insurance plans, pension plans and other plans, benefits or bonus arrangements provided by the Company from time to time during your term of employment under this Agreement and made available by the Company to its executives generally, if and to the extent that you are eligible to participate in accordance with the provisions of any such plan or for such benefits. Specifically, you shall be entitled to participate in the Company’s stock option plans and shall continue to be entitled to participate in the Company’s pension and disability plans and be provided with reimbursement of club memberships and automobile expenses as under present practices. In no event shall the benefits provided you be less, in the aggregate, than those provided you under present plans and practices. Life and health insurance benefits, reimbursement of club memberships and automobile expenses shall continue for you and your wife during the terms of your lives. In addition, the Company shall reimburse you for your reasonable personal legal and accounting expenses related to your estate and tax planning and to preparing and filing your tax returns. The split dollar life insurance coverage will continue under current practices.

-2-

5. Termination of the Term of Employment.

(a) Termination Other Than for Just Cause.

If at any time during your term of employment under this Agreement, the Company shall terminate your employment under this Agreement, other than for “just cause” as such term is defined in paragraph (c) of this Section 5, such event shall be deemed a termination other than for just cause. After a termination other than for just cause, you shall have no obligations under this Agreement (other than your obligations under Section 7 and 8 of this Agreement), you shall have no obligation to seek other employment in mitigation of damages in respect of any period following the date of such termination and you shall be entitled to receive from the Company (1) your then base annual salary through the end of the month during which such termination occurs, (2) continued coverage under the benefit plans of the Company specified in paragraph (c) of Section 4 of this Agreement pursuant to the terms and periods specified in paragraph (c) of Section 4, (3) reimbursement of any business expenses incurred through the end of your employment and (4) any other amounts or benefits that are earned, accrued or vested through the end of your employment under any other plans or arrangements of the Company (your “Accrued Compensation”). In addition, if the Company shall terminate your employment other than for just cause, (1) all equity awards issued by the Company to you will vest and become immediately exercisable and (2) all such equity awards granted after the date hereof will remain exercisable for 24 months after the end of your employment (or, if earlier, until they would have expired but for your termination).

(b) Other Terminations.

If your employment under this Agreement shall terminate under any circumstances other than those described in paragraph (a) of Section 5, the Company shall only be obligated to pay you your Accrued Compensation.

(c)Definition of Just Cause.

“Just cause” under this Agreement shall mean a breach by you of your obligations under this Agreement, willful misconduct, dishonesty, conviction of a crime (other than traffic or other similar violations or minor misdemeanors), intoxication on the job or excessive absenteeism not related to illness.

6. Effect of Change in Control.

In the event that a Change in Control, as that term is defined in the May 22, 2000 Change in Control Severance Agreement entered into between you and the Company (the “Change in Control Agreement”), occurs following the Effective Date and during the term of your employment under this Agreement, (1) you shall continue to be entitled to receive the Gross-Up Payment provided under Section 5 of the Change in Control Agreement and (2) if such Change in Control occurs within twelve months following the Effective Date, all of the other terms of the Change in Control Agreement will continue to apply. If such a Change in Control does not occur within twelve months

-3-

after the Effective Date of this Agreement, the terms of the Change in Control Agreement shall be deemed to have been terminated, except with respect to the the foregoing item (1) in this paragraph.

7. Non-competition.

It is agreed that during your term of employment under this Agreement and for a period of two years thereafter you will not, without the prior written approval of the Board of Directors of the Company become an officer, employee, agent, limited or general partner, director, member or shareholder of any business enterprise in competition with the Company or any subsidiary of the Company, as the business of the Company or any such subsidiary may be constituted during such term of employment, or at the expiration of such term or period; provided, however, that the foregoing shall not require you to terminate or alter the nature or extent of your relationships with Mohawk Hospital Equipment, Inc. as they existed on the date of this Agreement, or any successor of such corporation. Notwithstanding the preceding sentence, you shall not be prohibited from owning less than five (5%) percent of the outstanding equity of any publicly traded business enterprise.

8.Non-disclosure.

You shall not, at any time during or following your term of employment under this Agreement, disclose or use, except in the course of your employment or consultation arrangements with the Company in the pursuit of the business or interests of the Company or any of its subsidiaries or affiliates, any confidential information or proprietary data of the Company or any of its subsidiaries or affiliates, whether such information or proprietary data is in your memory or memorialized in writing or other physical terms.

9.Conflicts.

Any paragraph, sentence, phrase or other provision of this Agreement which is in conflict with any applicable statute, rule or other law shall be deemed, if possible, to be modified or altered to conform thereto or, if not possible, to be omitted herefrom. The invalidity of any portion of this Agreement shall not affect the force and effect of the remaining valid portions hereof. Section and paragraph headings are included in this Agreement for convenience only and are not intended to affect in any way the meaning or interpretation of this Agreement.

10.Beneficiaries.

Wherever this Agreement provides for the written designation of a beneficiary or beneficiaries by yourself, you shall have the right to revoke such designation and to redesignate a beneficiary or beneficiaries by written notice to the Company to such effect.

-4-

11.Governing Law.

This Agreement is governed by and is to be construed and enforced in accordance with the laws of the State of New York.

12.Miscellaneous.

Upon the Effective Date, this Agreement shall constitute the entire understanding between you and the Company relating to your employment with the Company and supersedes and cancels all prior written and oral understandings and agreements with respect to such matters, other than with respect to the deferred compensation account under Section 4(b). This Agreement shall be binding upon, and shall inure to the benefit of you and the Company, your heirs, executors and administrators and the Company’s successors.

-5-

If the foregoing correctly sets forth the understanding between you and the Company, please execute and return the enclosed copy of this letter.

	CONMED CORPORATION
By:	/s/ Daniel S. Jonas
	Daniel S. Jonas

Agreed and accepted as of the date first above written:

/s/ Eugene R. Corasanti

Eugene R. Corasanti

-6-

EX-10.2

Exhibit 10.2

Amendment No. 1 to

November 12, 2004 Employment Agreement

AGREEMENT made this 31st day of October, 2006 between CONMED Corporation and Joseph J. Corasanti as follows:

WHEREAS, the Company and Joseph J. Corasanti have agreed to amend the provisions of his Employment Contract.

NOW, THEREFORE, in consideration of One Dollar and all other good and valuable consideration the parties hereto do hereby agree as follows:

1. Effective January 1, 2007, Section 1 of the Employment Contract is amended in its entirety to provide as follows:

“The Company hereby agrees that you will be employed to serve as President and Chief Executive Officer of the Company during the remaining term of employment set forth in Section 2 of this Agreement. You hereby agree to serve, effective January 1, 2007, as President and Chief Executive Officer of the Company during such term of employment.”

2. Effective January 1, 2007, the following shall be added at the end of the first sentence of Section 4(a) of the Employment Contract:

“, provided, that after January 1, 2007 such annual base salary shall be at a rate of at least $450,000.”

3. Effective January 1, 2007, the following shall be added at the end of the first sentence of the second paragraph of Section 4(b) of the Employment Contract:

“, provided that beginning on December 31, 2007 and each subsequent December 31 during the term of this Agreement, such amount credited shall be $150,000.”

	CONMED CORPORATION
/s/ Joseph J. Corasanti	By:	/s/ Daniel S. Jonas
Joseph J. Corasanti		Daniel S. Jonas